Novo Nordisk to Put $100 Million in its China R&D Center

Novo Nordisk said it will commit up to $100 million to expand its Beijing R&D center. As much as $40 million of that will go to build new labs for diabetes research. The company plans to have the new labs finished late next year and occupy them in 2012. Most of this information added details to the company’s September announcement that it would expand its Beijing R&D operation. More details.... Stock Symbol: (NYSE: NVO)